Latest News & Features
Americas
A US judge has said Teva Pharmaceuticals did not infringe patents belonging to a rival company after seeking approval to market a generic version of the drug. 15 January 2014
Biotechnology
UK law firm Potter Clarkson LLP has made changes to its team with the appointment of two senior managers. 15 January 2014
Americas
IP law firm Sterne Kessler Goldstein & Fox PLLC has announced the election of three new directors to its life sciences team. 14 January 2014
Americas
The US Supreme Court has refused to hear the Organic Seed Growers and Trade Association’s case against Monsanto, along with two other patent cases as revealed in a document released on January 13. 14 January 2014
Americas
On January 10, the US Supreme Court agreed to decide on so-called ambiguous patent claims in Nautilus v Biosig Instruments. 14 January 2014
Americas
General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion. 13 January 2014
Americas
Biopharmaceutical company Alnylam has paid Merck $175 million for its subsidiary Sirna Therapeutics, a firm specialising in RNA interference therapeutics. 13 January 2014
Americas
Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field. 13 January 2014
Big Pharma
Three December decisions from the Court Of Justice of the European Union shed light on supplementary protection certificates in Europe. 13 January 2014
Americas
Edwards Wildman Palmer LLP has hired Edward Glynn, a former senior official at the Federal Trade Commission. 9 January 2014